Back
Enanta Pharmaceuticals 10K Form
Sell
29
ENTA
Enanta Pharmaceuticals
Last Price:
$5.50
Seasonality Move:
-2.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2024-02-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2023-08-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2023-05-09 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2023-02-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2022-08-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
Receive ENTA News And Ratings
See the #1 stock for the next 7 days that we like better than ENTA
ENTA Financial Statistics
Sales & Book Value
| Annual Sales: | $67.6M |
|---|---|
| Cash Flow: | $-25.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.24 |
| Price / Book: | 1.05 |
Profitability
| EPS (TTM): | -4.95000 |
|---|---|
| Net Income (TTM): | $-104.9M |
| Gross Margin: | $0 |
| Return on Equity: | -70.18% |
| Return on Assets: | -26.68% |
Enanta Pharmaceuticals Earnings Forecast
Key Enanta Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 4 years for ENTA is 0.00%.
-
The Selling, General & Administrative Expenses for ENTA have been equal to 85.53% of Gross Profit Margin.
-
The Research & Development expenses have been 194.39% of Revenue.
-
The Net Earning history of ENTA is -171.58% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 5 years.
Enanta Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENTA |
| CUSIP: | 29251M |
| Website: | enanta.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.47 |
| Quick Ratio: | 5.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ENTA Technical Analysis vs Fundamental Analysis
Sell
29
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a SellThe current Enanta Pharmaceuticals [ENTA] share price is $5.50. The Score for ENTA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.